SCHEMBL422072

SCHEMBL422072

C=C1CCC(=O)N1OC(=O)CCOCCC(=O)CN1C(=O)CCC1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23915498 0.90 SMN1; SMN2 (0.31) —
SCHEMBL15147492 0.89 ALDH1A1 (0.33) —
SCHEMBL20364862 0.89 ALDH1A1 (0.33) —
SCHEMBL16884595 0.89 ALDH1A1 (0.33) —
SCHEMBL126773 0.87 — —
SCHEMBL17928352 0.86 — —
SCHEMBL18751741 0.86 — —
SCHEMBL18914924 0.83 — —
SCHEMBL12690459 0.81 HPGD (0.36) —
SCHEMBL18751732 0.81 HPGD (0.36) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120064107-A1 COMPOSITIONS AND METHODS FOR TREATMENT OF AUTOIMMUNE AND OTHER DISEASE CERULEAN PHARMA INC. (US) 2012-03-15 — — US disclosed
Send feedback